Literature DB >> 10967506

Changes in the incidence of inflammatory bowel disease: what does it mean?

.   

Abstract

A sharp rise in the incidence of inflammatory bowel disease (IBD) has been observed in the western world since the early 1950s. The increase in the incidence of ulcerative colitis preceded the increase in the incidence of Crohn's disease by about 10-15 years. In high-incidence areas, a female preponderance at a young age (20-40 years) is observed in Crohn's disease, whereas in ulcerative colitis male incidence is still high at older ages. IBD is more common in the developed world than in the developing world and, in both the United States and Europe, a north-south incidence gradient has been reported, with IBD more common in the north than in the south. There are also indications that, in typically low-incidence areas, more cases are being seen lately. At present, IBD is rather common in western Europe, affecting 0.5-1.0% of the population during their lifetime. It will be interesting to follow these temporal trends in the coming years, as they may teach us more about the role of environmental factors in the pathogenesis of IBD.

Entities:  

Year:  2000        PMID: 10967506     DOI: 10.1016/s0953-6205(00)00090-x

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  22 in total

1.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 2.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 5.  Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.

Authors:  Ammar Hassanzadeh Keshteli; Vickie E Baracos; Karen L Madsen
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

6.  Transition of Care in Inflammatory Bowel Disease.

Authors:  Bincy P Abraham; Stacy A Kahn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

7.  Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.

Authors:  O Höie; L J Schouten; F L Wolters; I C Solberg; L Riis; I A Mouzas; P Politi; S Odes; E Langholz; M Vatn; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

8.  Mortality in ulcerative colitis-what should we tell our patients? Three year mortality following admission for the treatment of ulcerative colitis: a 6 year retrospective case review.

Authors:  J Falvey; R Greenwood; T J Creed; J Smithson; P Sylvester; A Fraser; C S Probert
Journal:  Frontline Gastroenterol       Date:  2010-04-01

Review 9.  Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

Authors:  Peter-Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

10.  Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis.

Authors:  Wangui Yu; Bing Lu; Hengwen Zhang; Yanxiang Zhang; Jin Yan
Journal:  Biomed Rep       Date:  2016-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.